AAA
BGMS

Affinity Asset Advisors’s Bio Green Med Solution Inc BGMS Stock Holding History

Affinity Asset Advisors’s Portfolio BGMS Stock Details BGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-111
Closed -$1.22M – 59
2022
Q1 		$1.22M Hold
111
– – 0.2% 44
2021
Q4 		$1.55M Hold
111
– – 0.56% 42
2021
Q3 		$2.11M Buy
111
+5
+5% +$96.2K 0.53% 38
2021
Q2 		$2.25M Hold
106
– – 0.81% 31
2021
Q1 		$2.7M Buy
106
+73
+221% +$2.06M 0.92% 28
2020
Q4 		$918K Buy
+33
New +$505K 0.49% 41

Other funds holding BGMS

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Affinity Asset Advisors's BGMS Position: Q2 2022 in Review

Affinity Asset Advisors sold out of Bio Green Med Solution Inc (BGMS) in Q2 2022, closing a stake of 111 shares — an estimated $1.22M sold.

Affinity Asset Advisors first reported a position in BGMS in Q4 2020 and held it in 6 quarters. The position peaked at $2.7M in Q1 2021. 19 funds tracked by Wall St. Rank hold BGMS as of Q2 2022.

  • Affinity Asset Advisors reported no remaining Bio Green Med Solution Inc position as of Q2 2022 after selling out during the quarter.
  • Affinity Asset Advisors sold 111 Bio Green Med Solution Inc shares in Q2 2022, an estimated $1.22M.
  • Affinity Asset Advisors first reported a position in Bio Green Med Solution Inc in Q4 2020 and held it in 6 quarters.
  • Affinity Asset Advisors's Bio Green Med Solution Inc position peaked at $2.7M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q2 2022.

Based on Affinity Asset Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.